Henrik Svanström

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL INFECTIOUS DISEASES. 2021;72(12):e1084-e1089
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
Inghammar M; Svanstrom H; Voldstedlund M; Melbye M; Hviid A; Molbak K; Pasternak B
Article: JAMA PEDIATRICS. 2021;175(4):394-403
Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Article: CLINICAL DRUG INVESTIGATION. 2020;40(12):1147-1154
Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
Wintzell V; Svanstrom H; Melbye M; Ludvigsson JF; Pasternak B; Kulldorff M
Article: DRUG SAFETY. 2020;43(10):1035-1044
Use of Pregabalin and Worsening Heart Failure: A Nationwide Cohort Study
Lund M; Poulsen G; Pasternak B; Andersson NW; Melbyel M; Svanstrom H
Article: DIABETES CARE. 2020;43(6):1326-1335
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
Pasternak B; Wintzell V; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Melbye M; Svanstrom H; Ueda P
Article: JAMA PEDIATRICS. 2020;174(6):543-551
Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Article: THE BMJ. 2020;369:m1186
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak B; Wintzell V; Melbye M; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Svanstrom H; Ueda P
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2019;4(11):845-853
Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study
Wintzell V; Svanstrom H; Melbye M; Jess T; Olen O; Ludvigsson JF; Pasternak B
Article: THE BMJ. 2019;366:l4772
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Pasternak B; Ueda P; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Wintzell V; Melbye M; Svanstrom H
Article: THE LANCET CHILD AND ADOLESCENT HEALTH. 2019;3(3):158-165
Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study
Wintzell V; Svanstrom H; Olen O; Melbye M; Ludvigsson JF; Pasternak B
Article: THE LANCET DIABETES AND ENDOCRINOLOGY. 2019;7(2):106-114
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Svanstrom H; Ueda P; Melbye M; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Joivsson C; Pasternak B
Article: THE BMJ. 2018;363:k4365
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
Ueda P; Svanstrom H; Melbye M; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Pasternak B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;269:310-316
Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study
Lund M; Svanstrom H; Pasternak B; Hviid A; Melbye M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;268:113-119
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
Andersson NW; Svanstrom H; Lund M; Pasternak B; Melbye M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(8):885-893
Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis
Svanstrom H; Lund M; Melbye M; Pasternak B
Article: DRUG SAFETY. 2018;41(8):817-826
Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study
Svanstrom H; Lund M; Melbye M; Pasternak B
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2018;187(4):777-785
Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study
Inghammar M; Nibell O; Pasternak B; Melbye M; Svanstrom H; Hviid A
Article: THE BMJ. 2018;360:k678
Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study
Pasternak B; Inghammar M; Svanstrom H
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(2):154-165
Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases
Hviid A; Svanstrom H; Scheller NM; Gronlund O; Pasternak B; Arnheim-Dahlstrom L
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2017;376(13):1223-1233
Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes
Scheller NM; Pasternak B; Molgaard-Nielsen D; Svanstrom H; Hviid A
Article: THE BMJ. 2016;352:i843
Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
Inghammar M; Svanstrom H; Melbye M; Pasternak B; Hviid A
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2015;313(1):54-61
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Scheller NM; Svanstrom H; Pasternak B; Arnheim-Dahlstrom L; Sundstrom K; Fink K; Hviid A
Article: PLOS ONE. 2014;9(1):e82222
Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe
Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanstrom H; Molgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlstrom L; Sparen P; Mosseveld M; Schuemie M; van der Mass N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MCJM
Article: THE BMJ. 2013;347:f5906
Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
Arnheim-Dahlstrom L; Pasternak B; Svanstrom H; Sparen P; Hviid A
Article: VACCINE. 2013;31(8):1246-1254
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanstrom H; Molgaard-Nielsen D; Heijbel H; Dahlstrom LA; Hallgreng J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MCJM
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2012;21(8):890-895
Use of amiloride and multiple sclerosis: registry-based cohort studies
Pasternak B; Svanstrom H; Nielsen NM; Melbye M; Hviid A
Article: THE BMJ. 2012;344:e2794
Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark
Pasternak B; Svanstrom H; Molgaard-Nielsen D; Krause TG; Emborg H-D; Melbye M; Hviid A
Article: VACCINE. 2012;30(19):3042-3046
A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.
Andrews N; Stowe J; Miller E; Svanström H; Johansen K; Bonhoeffer J; Hviid A; VAESCO consortium
Visa fler

Alla övriga publikationer

Letter: DIABETES CARE. 2019;42(6):e92-e94
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries
Ueda P; Pasternak B; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Melbye M; Svanstrom H
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;190:4-6
Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure
Pasternak B; Mattsson A; Svanstrom H; Hviid A

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI